Nantahala Capital Management, LLC Jasper Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.55 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
BUY
$0.42 - $0.93 $935,871 - $2.07 Million
2,228,265 New
2,228,265 $1.76 Million
Q3 2023

Nov 14, 2023
SELL
$0.68 - $1.54 $50,983 - $115,463
-74,976 Reduced 3.03%
2,402,904 $1.68 Million
Q2 2023

Aug 14, 2023
BUY
$1.19 - $1.79 $939,416 - $1.41 Million
789,426 Added 46.75%
2,477,880 $3.39 Million
Q1 2023

May 15, 2023
BUY
$1.48 - $2.74 $2.5 Million - $4.63 Million
1,688,454 New
1,688,454 $3.06 Million

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $962M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email